C164H180F4N28O6 — CID 158380027
(2R)-2-[[(2S)-2-(2-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide (PubChem CID 158380027) has the molecular formula C164H180F4N28O6 and a molecular weight of 2715.43 g/mol. Its IUPAC name is (2R)-2-[[(2S)-2-(2-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide.
| Compound Name | (2R)-2-[[(2S)-2-(2-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide |
|---|---|
| PubChem CID | 158380027 |
| Molecular Formula | C164H180F4N28O6 |
| Molecular Weight | 2715.43 g/mol |
| Exact Mass | 2713.46 |
| IUPAC Name | (2R)-2-[[(2S)-2-(2-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2S)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2R)-2-[[(2R)-2-(3-fluoro-4-methylphenyl)propyl]amino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-phenylacetamide;(2S)-2-[[(2R)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide;2-[[(2S)-2-(4-methylphenyl)propyl]amino]-N-[5-[(3R)-3-methylpyrrolidin-1-yl]-2-pyridinyl]-2-phenylacetamide |
| SMILES | Cc1ccc([C@@H](C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F.Cc1ccc([C@@H](C)CN[C@H](C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CNC(C(=O)Nc2ccc(N3CC[C@@H](C)C3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)c(F)c1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2ccccc2)cc1F |
| InChI | InChI=1S/2C28H34N4O.4C27H28FN5O/c2*1-20-9-11-23(12-10-20)22(3)17-30-27(24-7-5-4-6-8-24)28(33)31-26-14-13-25(18-29-26)32-16-15-21(2)19-32;1-18-9-11-23(24(28)13-18)19(2)14-30-26(20-7-5-4-6-8-20)27(34)32-25-12-10-21(15-29-25)22-16-31-33(3)17-22;3*1-18-9-10-21(13-24(18)28)19(2)14-30-26(20-7-5-4-6-8-20)27(34)32-25-12-11-22(15-29-25)23-16-31-33(3)17-23/h2*4-14,18,21-22,27,30H,15-17,19H2,1-3H3,(H,29,31,33);4*4-13,15-17,19,26,30H,14H2,1-3H3,(H,29,32,34)/t21-,22+,27+;21-,22-,27?;19-,26-;2*19-,26+;19-,26-/m111100/s1 |
| InChIKey | GVRCXCCPAMVNCM-AUNSQSDPSA-N |
| XLogP | 30.63 |
| TPSA | 401.88 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 202 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2715.43 |
| LogP ≤ 5 | 30.63 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 28 |